NVO Stock Gains As UK Clears First Daily GLP-1 Weight-Loss Pill, Offsetting Security Breach News
Novo Nordisk revealed that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Wegovy pill, following in the footsteps of the U.S. FDA.
Stocktwits
More News
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.
Zacks
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Sector ETF report for PPH
Zacks
REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief
The New York Times reported that Makary’s departure was driven in large part by his strong opposition to the administration’s decision to authorize fruit-flavored e-cigarettes.
Stocktwits
Trump Slaps 100% Tariffs On Imported Patented Drugs, Sparing Companies That Onshore Or Cut Prices
The new levies apply to patented drugs made in countries with which the U.S. have no tariff deals and by companies that haven’t inked drug pricing deals with the administration.
Stocktwits
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report
Pharmaceutical companies can avoid these tariffs if they move their manufacturing to the U.S. or are currently negotiating a deal with the Trump administration.
Stocktwits
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Sector ETF report for PPH
Zacks
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
Eli Lilly's $2.75B AI drug deal with Insilico spotlights healthcare ETFs as investors seek diversified exposure to the fast-growing AI-driven pharma space.
Zacks
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs
Novo Nordisk's FDA nod for higher-dose Wegovy could boost healthcare ETFs' appeal, offering diversified exposure to the obesity drug market.
Zacks
Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy
The company stated that Wegovy HD received the FDA’s accelerated approval based on results from the STEP UP trial.